Medical Hypotheses
Volume 55, Issue 5 , Pages 452-453, November 2000

High-dose methylprednisolone may do more harm for spinal cord injury

  • T. Qian

      Affiliations

    • Department of Physical Medicine & Rehabilitation, UMDNJ – New Jersey Medical School, Newark, New Jersey, USA
  • ,
  • D. Campagnolo

      Affiliations

    • Department of Physical Medicine & Rehabilitation, UMDNJ – New Jersey Medical School, Newark, New Jersey, USA
  • ,
  • S. Kirshblum

      Affiliations

    • Kessler Institute for Rehabilitation, West Orange, New Jersey, USA

Received 3 February 2000; accepted 1 June 2000.

Abstract 

Because of the National Acute Spinal Cord Injury Studies (NASCIS), high-dose methylprednisolone became the standard of care for the acute spinal cord injury. In the NASCIS, there was no mention regarding the possibility of acute corticosteroid myopathy that high-dose methylprednisolone may cause. The dosage of methylprednisolone recommended by the NASCIS 3 is the highest dose of steroids ever being used during a 2-day period for any clinical condition. We hypothesize that it may cause some damage to the muscle of spinal cord injury patients. Further, steroid myopathy recovers naturally and the neurological improvement shown in the NASCIS may be just a recording of this natural motor recovery from the steroid myopathy, instead of any protection that methylprednisolone offers to the spinal cord injury. To our knowledge, this is the first discussion considering the possibility that the methylprednisolone recommended by NASCIS may cause acute corticosteroid myopathy.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0306-9877(00)91165-4

doi:10.1054/mehy.2000.1165

Medical Hypotheses
Volume 55, Issue 5 , Pages 452-453, November 2000